Studies involving chick embryos have implicated FGFs in neural induction and patterning as well as in other developmental events. Detailed analyses of FGF receptor expression at early stages of neural development have not been reported for the chick embryo and are incomplete for other vertebrate classes. Here we show the expression patterns of three FGF receptors, (FGFR1, FGFR2 and FGFR3) in embryonic stages between gastrulation and limb bud formation, focussing particularly on neural tissues. Between neural induction and neurulation, all three receptors are expressed in the neural plate albeit with distinct and overlapping distributions. During early neuromere formation FGFR1 transcripts are present throughout the neural tube, while transcripts for FGFR2 and FGFR3 become restricted to regions of the diencephalon and spinal cord. A little later, FGFR2 and FGFR3 are additionally expressed in the anterior midbrain and within the hindbrain. During later neuromere development, FGFR1 transcripts become localised to the telencephalon, anterior dorsal diencephalon and throughout the midbrain and hindbrain, whereas FGFR2 mRNA is restricted to dorsal telencephalon, dorsoanterior midbrain and hindbrain. FGFR3 is also expressed in anterior midbrain and hindbrain during this developmental period, and is additionally expressed in the posterior telencephalon, in the pretectum, and at the zona limitans intrathalamica. The observed expression patterns of all three receptors within the hindbrain, including rhombomere boundaries, are complex and dynamic. Expression patterns within the somites, eye, head mesenchyme, branchial arches, limb buds, nephric kidney and pharynx are also described. q
Results
Fibroblast growth factors (FGFs) have recently been implicated as regulators of many key processes during early neural development. In particular, studies in avian embryos have shown that FGF can induce neural tissue from naive epiblast (Alvarez et al., 1998; Storey et al., 1998) and exerts a posteriorising in¯uence on newly-formed neural tissue (Muhr et al., 1997) . Other experiments provide evidence for vertical signalling by FGF4 in regulating midbrain speci®cation (Shamim et al., 1999a) , for FGF8 as the isthmic organising activity regulating midbrain polarisation and proliferation (Crossley et al., 1996; Sheikh and Mason, 1996; Martinez et al., 1999; Shamim et al., 1999a) and for FGF8 in patterning anterior forebrain (Shimamura and Rubenstein, 1997) . At later stages FGFs have been implicated in formation of the retinotectal projection by regulating Ephrin expression (Shamim et al., 1999) , in development of rhombomere boundaries and in induction of the otic vesicle (Represa et al., 1991; Mahmood et al., 1995 Mahmood et al., , 1996 . It is therefore surprising that studies of FGF receptor (FGFR) expression at stages relevant to these processes are largely incomplete. Reports concerning three of the four FGFRs, FGFR1, 2 and 3, mostly concern later stages of neural development (Heuer et al., 1990; Patstone et al., 1993; Wilke et al., 1997; Philippe et al., 1998) , and a detailed study of the fourth FGFR, FGFR4, indicates that it is not expressed within the developing neural tube (Marcelle et al., 1994) . In this paper we present a detailed analysis of FGFR1, 2 and 3 expression during early avian development with particular emphasis on the nervous system. We report complex dynamic spatiotemporal changes in transcript distribution for all receptors in that tissue, not previously reported in studies of other vertebrates, and identify those receptor isoforms likely to be responsible for mediating the signalling events described above. Moreover, we provide the ®rst comparative report of FGFR expression in the developing avian limb bud, a system in which multiple FGFs are differentially expressed and are believed to have different functions (Martin, 1998) .
Transcripts for all three FGFRs were present during the period of neural induction. FGFR1 was expressed in epiblast, presumptive neural plate and mesendodermal cells throughout the embryo (Fig. 1A,D) . FGFR2 was also detected with highest apparent transcript levels in presumptive neural plate adjacent to the head process and in anterior primitive streak. Few or no transcripts were present in cells migrating through the primitive groove or in mesendoderm (Fig. 1B,E) . By contrast, highest FGFR3 levels were detected in lateral ectoderm particularly anterior to Hensen's node. Expression was apparently absent from medial ectoderm, primitive streak and mesendoderm (Fig.  1C,F) .
To determine which FGFR splice variants were present at this stage, cDNAs corresponding to the three receptors were ampli®ed from Hamburger and Hamilton stage (HH) 4-6 embryos by RT-PCR (for explanation of RT-PCR strategy see Section 2). Digestion of the FGFR1 PCR product with Acc1 resulted in cleavage products of 835 and 580 base pairs (bp), indicating the presence of the IIIb isoform, and also of 400 and 180 bp, indicating the presence of the IIIc isoform. The IIIc isoform of FGFR1 appeared to be more abundant since the Acc1 digest resulted in more of the 400 bp product than the 580 bp product. The use of FGFR2 isoform-speci®c primers during RT-PCR revealed the presence of both Sam (FGFR2iiib) and Bek (FGFR2iiic) isoforms in these embryos as well. Digestion of the FGFR3 PCR product with EcoRI resulted in cleavage products of 395 and 258 bp indicating the presence of the IIIc isoform, as well as an uncut product of 653 bp corresponding to the IIIb isoform. The predominant isoform present appeared to be FGFR3iiic (Fig. 1G) . Control RT-PCR experiments performed with RNA-negative samples excluded the possibility of FGFR2 PCR products being generated from cDNA contaminated with genomic DNA. Also, the results for FGFR1 and FGFR3 could not be accounted for by genomic DNA contamination since the primers used during RT-PCR ampli®ed cDNAs spanning several exons (data not shown).
As the neural folds began to close and fuse, prior to the appearance of neuromeres, elevated levels of all three receptors were detected in the anterior neural plate (Fig. 2A±C) . As neuromeres formed FGFR1 transcripts were detected throughout the neural tube (Fig. 2D,H ) and FGFR2 transcripts became con®ned to the diencephalon and spinal cord (Fig. 2E,I ). During this period FGFR3 transcripts were also detected in the diencephalon but were additionally found in the¯oorplate of the midbrain and in anterior spinal cord adjacent to the ®rst 6±7 somites (Fig. 2F,J) . FGFR isoform expression was examined in diencephalic neural tissue from embryos of HH 9±11 by RT-PCR. The results . d, diencephalon; e, ectoderm; en, endoderm; f, foregut; k, keel of pharynx; lm, lateral plate mesoderm; hb, hindbrain; m, mesendoderm; mb, midbrain; mes, mesenchyme; n, notochord; nt, neural tube; ps, primitive streak; s, somite; sm, splanchnic mesoderm; sp, segmental plate mesoderm; t, telencephalon.
showed that both the IIIb and IIIc isoforms of FGFR1 and FGFR2, but only the IIIc isoform of FGFR3, were present (Fig. 2G) .
FGFRs 1, 2 and 3 had contrasting patterns of expression in developing somites. At the onset of somitogenesis, diffuse expression of FGFR1 was detected in somites and segmental plate ( Fig. 2A) . At later stages, expression was absent in somites but remained in anterior segmental plate (Fig. 2H,K,N,Q) . FGFR2 was diffusely and transiently expressed in the ®rst few somites to form (Fig. 2B ) but, at later stages, little or no FGFR2 mRNA was detected in somites (Fig. 2I,R) . By contrast, high levels of FGFR3 transcripts were detected in the most recently formed somites throughout somitogenesis, with elevated levels posteriorly, (Fig. 2C,J) but not in differentiating somites or in segmental plate ( Fig. 2M,P,S) .
FGFR transcripts were also detected in a number of other tissues at these stages. Most notably, FGFR2 expression was detected in ectoderm, head mesenchyme adjacent to the diencephalon and midbrain (Fig. 2E,L) , in the keel of the pharynx, embryonic endoderm, splanchnic mesoderm, lateral plate mesoderm and notochord (Fig. 2E ,L,O,R). FGFR3 transcripts were additionally detected in lateral plate mesoderm, splanchnic mesoderm, endoderm and notochord (Fig. 2M) .
FGFRs 1, 2 and 3 were all expressed in head mesenchyme during early chick embryogenesis to varying degrees. Therefore, in order to obtain a clear view of receptor expression patterns in the brain it was necessary to remove the head ectoderm and mesenchyme after whole-mount in situ hybridisation (Compare Fig. 3A±C with D±F and J±L with M±O).
As observed at earlier stages, all areas of the brain expressed FGFR1 during neuromere formation and maturation (Fig. 3D) . Within the hindbrain, FGFR1 was strongly expressed in dorsal aspects of rhombomere (r) 1 corresponding to the presumptive rhombic lip. Apparent transcript levels were elevated in rhombomere boundaries but were more weakly expressed in the bodies of all rhombomeres (Fig. 3G ). Boundary expression persisted until at least HH 22, at which time, a prominent anteroposterior oriented strip of expressing cells was observed extending caudad from posterior r1 (Fig. 3P) . FGFR1 was expressed in the telencephalon, dorsoanterior dorsal thalamus and throughout the midbrain at HH 21 (Fig. 3M) and weak expression was detected in the spinal cord in the stages examined (Fig.  4G,J) . FGFR1 cDNA was ampli®ed from anterior midbrain and hindbrain neural tissue collected from HH 17 and HH 21 embryos and digested with Acc1. The resulting cleavage products indicated that both the IIIb and IIIc isoforms were present in both brain regions at HH 17 (data not shown) and HH 21 (Fig. 3S,T) .
FGFR1 transcripts were also detected in head mesenchyme, lens and retina at HH 17 (Fig. 4A) . Expression was still present in head mesenchyme at HH 21, being particularly elevated around the retina, whereas transcript levels within the eye had declined relative to surrounding mesenchyme by this stage (Fig. 4D) .
By contrast, FGFR2 had a more restricted pattern of expression than FGFR1 in the brain at these stages. Between HH 12 and HH 17 FGFR2 transcripts were detected in the diencephalon and anterior midbrain. Analysis at HH 17 showed expression in the dorsal diencephalon, dorsal anterior midbrain and dorsal hindbrain (Fig. 3E) . Detailed analysis of the hindbrain showed that transcripts ®rst appeared in r1 and r2 in the hindbrain (data not shown) but by HH 17 were present in dorsal areas of all rhombomeres (Fig. 3H) . Again, there was evidence for expression within rhombomere boundaries, particularly at HH 22 while, within rhombomeres, transcripts became organised into discrete bands extending throughout the anteroposterior axis from r2 caudad (Fig. 3Q) . By HH 21 FGFR2 transcripts had largely disappeared from the diencephalon but were detected in the dorsal telencephalon and dorsal anterior midbrain (Fig. 3N) . FGFR2 expression became progressively downregulated in anterior regions of the spinal cord during these stages (Fig.  4H,K) . In general, expression was strongest in the region of the spinal cord which had most recently fused at the dorsal midline but was absent in unfused neural folds posteriorly (data not shown). RT-PCR was performed on anterior midbrain and hindbrain samples from HH 17 and HH 21 embryos using isoform-speci®c FGFR2 primers. FGFR2iiib and FGFR2iiic isoforms were detected in both brain regions at both stages, however, compared with PCR products obtained from anterior midbrain samples, FGFR2iiic cDNAs were barely detectable in hindbrain samples (Fig.  3S ,T and data not shown).
FGFR2 was expressed in head mesenchyme at all stages examined. By HH 21, more FGFR2 transcripts were detected in mesenchyme surrounding the eye than in other areas of head mesenchyme (Figs. 3K and 4B,E). FGFR2 was not expressed in the retina or lens at this or later stages (Fig.  4B,E) . FGFR3 was expressed in the diencephalon from its morphological appearance and this pattern continued during neuromere formation. However, more extensive expression was detected in HH 18 brains, transcripts being particularly abundant within the dorsal and ventral diencephalon, anterior midbrain and most of the hindbrain. Expression was notably absent from posterior midbrain and anterior r1 (Fig. 3F) . As observed for FGFR2, FGFR3 transcripts were present in the hindbrain from about HH 12 and were excluded from the anterior regions of r1, but were present throughout the rest of the hindbrain (Fig. 3I,R) . It was notable that transcripts for all three FGFRs were detected in rhombomere boundaries and that they became organised into discrete, but distinct, anteroposteriorly oriented bands extending from posterior r1 (Fig. 3P±R) . At HH 21 FGFR3 transcripts were present in the posterior telencephalon, around the zona limitans intrathalamica, in the pretectum, basal plate and in the anterior midbrain (Fig. 3O) . FGFR3 was expressed in the spinal cord from early stages and by HH 21 transcripts were present in the roofplate,¯oorplate and in intermediate regions (Fig. 4L ). Transcripts were also present in dorsal root ganglia (Fig. 4Y) . FGFR3 cDNA was ampli®ed from anterior midbrain and hindbrain neural tissue collected from HH 17 and HH 21 embryos and digested with EcoRI which cut the IIIc isoform speci®cally. The resulting cleavage pattern indicated that only the IIIc isoform was present in both brain regions at HH 17 and HH 21 (Fig. 3S ,T and data not shown).
Compared with FGFR1 and FGFR2, there was relatively little FGFR3 expression in head mesenchyme (Fig. 3C ) but transcripts were detected between the diencephalon and retina. The retina itself did not express FGFR3, but strong expression was detected in the lens at least until HH 21 (Fig.  4C,F) .
The three receptors had differential patterns of expression during nephric kidney development. At HH 17, FGFR1 was expressed throughout trunk tissues (Fig. 4G) , while FGFR2 was expressed in the nephric ducts (Fig. 4H) and FGFR3 in the nephrogenous mesenchyme (which is destined to become the mesonephros) adjacent to the nephric duct (Fig. 4I) . FGFR3 transcripts were mostly lost from the kidney at later stages while FGFR2 expression persisted in the nephric duct (data not shown).
During early branchial arch development FGFR1 was diffusely expressed in all of the arches (Fig. 4M) . Sections of these embryos revealed FGFR1 expression in both the ectoderm and endoderm and, more weakly, in the arch mesenchyme (data not shown). At HH 21 increased levels of FGFR1 were detected in arches 1 and 2 compared with posterior arches (Fig. 4P) . FGFR2 was initially expressed predominantly in arches 1 and 2 (Fig. 4N ), but later was also detected in arch 3 and part of arch 4 (Fig. 4Q) . Sections showed strongest expression in arch ectoderm, weaker expression in medial pharyngeal endoderm and a notable absence of expression in endoderm of the branchial pouches (data not shown). Onset of FGFR3 expression was observed relatively late during branchial arch development. At later stages it was expressed in the posterior half of arch 1 and in a small anterior region of arch 2 (Fig. 4O,R) . Sections revealed FGFR3 transcripts in pouch endoderm and in the mesenchyme of posterior arch 1 and anterior arch 2 (data not shown).
During the period of limb bud induction and initial outgrowth, FGFR1 transcripts were detected throughout the bud mesenchyme and were absent from the ectoderm (Fig. 4S) . By contrast, FGFR2 transcripts were restricted to the ectoderm, including the apical ectodermal ridge (Fig.  4T ) and FGFR3 transcripts were entirely absent from the early limb bud (Fig. 4U) .
Just prior to HH 21 the respiratory system begins to form. The laryngo-tracheal groove forms in the ventral midline of the pharynx. Further posteriorly the trachea separates from the oesophagus and bifurcates to form two bronchi. FGFR2 was strongly expressed in the laryngo-tracheal groove, the trachea and bronchi during this period (Fig. 4V,W,X) . By contrast, FGFR3 was strongly expressed in a complimentary fashion in mesenchyme surrounding the gut and respiratory tracts (Fig. 4Y) .
In addition to the sites of expression described above, FGFR2 was notably expressed throughout the ectoderm of the embryo (Fig. 4H,K) and FGFR3 was detected in lateral mesoderm (Fig. 4I,Y) at the stages examined. showing FGFR3 expression in mesenchyme surrounding the oesophagus and bronchi. b, bronchus; drg, dorsal root ganglia; e, ectoderm; l, lens; lm, lateral mesoderm; nd, nephric duct; nm, nephrogenous mesenchyme; o, oesophagus; p, pharynx; r, retina; s, somite; sc, spinal cord; tr, trachea.
